Filter posts

BIO Submits Joint Supplemental Comments on the USPTO March Guidance

Last week BIO, alongside a number of member companies and private individuals, submitted supplemental comments …

The Washington Post: Are Patents the Problem?

Tamar Haspel, food columnist for the Washington Post, looks at the issue of seed patents …

Herbicides and 2, 4-D: Cutting Through the Controversy

A number of media outlets reported on last week’s decision by the USDA to approve …

Scientific Community Urges Obama to Support Biotechnology

A number of media outlets are reporting today on a letter to President Obama urging …

PTO Patent Examinations in the wake of Mayo and Myriad

Biotech patent applicants are finding themselves in uncharted waters.   After the Supreme Court’s decisions …

Therapeutic Licensing and M&A Deals

Licensing deals for therapeutic candidates in 2013 dropped to the lowest volume in at least …

Some People Get it, and Some Just Don’t

As a communications director in the agriculture industry, I have spent two decades using fact-based …

Debunking the Biotech Bubble Talk

The Nasdaq Biotechnology Index (NBI) has been on a wild ride in 2014 with a …

Are GMOs the Climategate of the Left?

I’ve heard the word “momentum” a lot lately. Vermont signed its GMO labeling law on …

San Francisco Business Times: Two JOBS Acts are better than one

Today, the San Francisco Business Times published an op-ed by OncoMed President and CEO Paul Hastings lauding …